NATRILIX indapamide hemihydrate 2.5mg tablet Australia - English - Department of Health (Therapeutic Goods Administration)

natrilix indapamide hemihydrate 2.5mg tablet

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: maize starch; povidone; sodium lauryl sulfate; macrogol 6000; magnesium stearate; white beeswax; glycerol; titanium dioxide; lactose monohydrate; purified talc; hypromellose - natrilix is indicated in the management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally natrilix is used as the initial agent in multiple drug regimens.

VENTAVIS Israel - English - Ministry of Health

ventavis

bayer israel ltd - iloprost - solution for inhalation - iloprost 0.01 mg/ml - iloprost - treatment of patients with primary pulmonary hypertension (pph) or secondary pulmonary hypertension (sph) . due to connective tissue disease or drug - induced, in moderate or severe stages of the disease. in addition, treatment of moderate or severe secondary pulmonary hypertension due to chronic pulmonary thromboembolism, where surgery is not possible.